MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$4,933K
(63.67%↑ Y/Y)
Provision for income tax
benefit
-$1,537K
(-174.96%↓ Y/Y)
Loss before income
taxes
-$6,470K
(54.24%↑ Y/Y)
Interest and other
income, net
$3,013K
(220.87%↑ Y/Y)
Gain from operations
-$9,483K
(34.30%↑ Y/Y)
Total revenues
$17,699K
(15.02%↑ Y/Y)
Total expenses
$27,182K
(-8.85%↓ Y/Y)
Selling, general and
administrative
$17,720K
(-3.54%↓ Y/Y)
Research and development
$5,829K
(-49.10%↓ Y/Y)
Restructuring expenses
$3,633K
Back
Back
Income Statement
source: myfinsight.com
Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH)